FDA.reportPublic FDA data

2.5 ML Lynozyfic 2 MG/ML Injection

RxCUI
2719497
RxNorm name
2.5 ML Lynozyfic 2 MG/ML Injection
Display name
2.5 ML Lynozyfic 2 MG/ML Injection
Full name
2.5 ML Lynozyfic 2 MG/ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:26

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761400Lynozyficlinvoseltamab-gcpt351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
e9fd0739-1b3f-4b8b-824a-1f0a902384d32.5 ML Lynozyfic 2 MG/ML InjectionSY6These highlights do not include all the information needed to use LYNOZYFIC safely and effectively. See full prescribing information for LYNOZYFIC. LYNOZYFIC™ (linvoseltamab-gcpt) injection, for intravenous use Initial U.S. Approval: 202520250702
e9fd0739-1b3f-4b8b-824a-1f0a902384d3Lynozyfic 5 MG per 2.5 ML InjectionSY6These highlights do not include all the information needed to use LYNOZYFIC safely and effectively. See full prescribing information for LYNOZYFIC. LYNOZYFIC™ (linvoseltamab-gcpt) injection, for intravenous use Initial U.S. Approval: 202520250702
e9fd0739-1b3f-4b8b-824a-1f0a902384d3LYNOZYFIC 5 MG in 2.5 ML InjectionPSN6These highlights do not include all the information needed to use LYNOZYFIC safely and effectively. See full prescribing information for LYNOZYFIC. LYNOZYFIC™ (linvoseltamab-gcpt) injection, for intravenous use Initial U.S. Approval: 202520250702
e9fd0739-1b3f-4b8b-824a-1f0a902384d32.5 ML linvoseltamab-gcpt 2 MG/ML Injection [Lynozyfic]SBD6These highlights do not include all the information needed to use LYNOZYFIC safely and effectively. See full prescribing information for LYNOZYFIC. LYNOZYFIC™ (linvoseltamab-gcpt) injection, for intravenous use Initial U.S. Approval: 202520250702